Purgo Labs
$54.99- Price / mg
- $5.50
- Document access
- Public link
Live UPS rate; free UPS 3 Day Select over $250
Three public US 10 mg Ipamorelin research listings compared on exact nominal size, availability, list price, shipping claim, document access, and source date.
Current answer. As of Jul 23, 2026, 3 confirmed in-stock listings run from $54.99 to $60.49, with a $55.00 median across the in-stock rows. All 3 seller pages remain visible below.
Live UPS rate; free UPS 3 Day Select over $250
$9.95 US; free over $150
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Live UPS rate; free UPS 3 Day Select over $250
Open vendor evidence profile →Public batch reports. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Purgo Labs row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter Ipamorelin vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Purgo LabsLowest confirmed in-stock list priceIn stock | $54.99Source confirmed | $5.50 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
02Prime PeptidesPublic testing routeIn stock | $55.00Source confirmed | $5.50 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
03Pepta LabsPrice updated Jul 21In stock | $60.49Source confirmed | $6.05 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact Ipamorelin 10 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The exact 10 mg page was in stock and described third-party HPLC purity and ESI-MS identity testing with the batch certificate available by request.
The seller spells the product Ipamorlin; its exact 10 mg variation was in stock with a public batch report dated June 21, 2026. Peptide Local did not verify the vial.
The seller page displayed a 10 mg option, ordering control, and public test-results route. Peptide Local recorded the route without authenticating custody or vial contents.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the Ipamorelin 10 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Purgo Labs is $5.50 lower before shipping.
Purgo Labs is $0.01 lower before shipping.
Prime Peptides is $5.49 lower before shipping.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
The public list price moved from $54.99 in Peptide Local's 2026-07-17 snapshot to $60.49 after four matching source checks. That is a $5.50 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 3 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete Ipamorelin price history →Open the full peptide price change record →FDA says compounded drugs containing ipamorelin acetate may pose immunogenicity and peptide-impurity risks, notes characterization complexity, and says important route-specific safety information is lacking.
Read the FDA source ↗Check benefits claims, human studies, side effects, and approval status →Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026This record resolves a name to the US laboratory research catalog tracked by Peptide Local. It does not establish authorization, lawful supply, medical use, or availability in the selected destination.
Read the FDA sourceU.S. Food and Drug Administration↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row3 currently confirmed in stock↓Ipamorelin is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search Ipamorelin on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 2 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
Health Canada names ipamorelin among examples of unauthorized injectable peptide drugs identified or seized in Canada. The record does not authenticate a different listing, seller, presentation, import route, or supply claim.
SAHPRA names ipamorelin among peptide products unlawfully marketed in South Africa and states that products intended to treat, prevent, or alter bodily functions must be registered before sale. That guidance does not authenticate a specific online listing or seller.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $54.99 from Purgo Labs. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
2 confirmed in-stock rows link to a public seller document route: Purgo Labs, Prime Peptides. The lowest of those rows is Purgo Labs at $54.99. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 10 mg nominal size. The current lowest row states: Live UPS rate; free UPS 3 Day Select over $250. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact Ipamorelin identity and 10 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These pair guides compare research-market identity, exact board size, seller overlap, price footprint, and evidence access. They do not rank effects or recommend personal use.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.